Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma.
暂无分享,去创建一个
Kazuhisa Uchiyama | Yoshihiro Inoue | Mitsuhiro Asakuma | Michihiro Hayashi | K. Uchiyama | Tetsunosuke Shimizu | Tetsunosuke Shimizu | Fumitoshi Hirokawa | F. Hirokawa | M. Asakuma | Y. Inoue | M. Hayashi
[1] S. Fan,et al. Prediction of Posthepatectomy Recurrence of Hepatocellular Carcinoma by Circulating Cancer Stem Cells: A Prospective Study , 2011, Annals of surgery.
[2] K. Komeda,et al. A novel method using the VIO soft-coagulation system for liver resection. , 2011, Surgery.
[3] S. Du,et al. A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy , 2009, Journal of surgical oncology.
[4] T. Kanematsu,et al. Predictor for Histological Microvascular Invasion of Hepatocellular Carcinoma: A Lesson from 229 Consecutive Cases of Curative Liver Resection , 2010, World Journal of Surgery.
[5] Hongxiang Liu,et al. CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma , 2011, BMC Cancer.
[6] J. Lee,et al. Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. , 2006, American journal of surgery.
[7] S. Fan,et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma , 2000, Cancer.
[8] Y. Qiu,et al. Adjuvant Therapy With Capecitabine Postpones Recurrence of Hepatocellular Carcinoma After Curative Resection: A Randomized Controlled Trial , 2010, Annals of Surgical Oncology.
[9] K. Shirabe,et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. , 1996, Gastroenterology.
[10] Masatoshi Tanaka,et al. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.
[11] L. Capussotti,et al. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[12] Chiun Hsu,et al. Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach. , 2010, Journal of hepatology.
[13] M. Monden,et al. Interferon-β Is More Potent Than Interferon-α in Inhibition of Human Hepatocellular Carcinoma Cell Growth When Used Alone and in Combination With Anticancer Drugs , 2003, Annals of Surgical Oncology.
[14] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[15] K. Chayama,et al. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—A prospective randomized study of hepatitis C virus–related liver cancer , 2000, Hepatology.
[16] H. Moriwaki,et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. , 1996, Digestion.
[17] S. Kawasaki,et al. Surgery for small liver cancers. , 1993, Seminars in surgical oncology.
[18] A. Tamori,et al. Effects of Long-Term Postoperative Interferon- Therapy on Intrahepatic Recurrence after Resection of Hepatitis C VirusRelated Hepatocellular Carcinoma , 2001, Annals of Internal Medicine.
[19] K. Endo,et al. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. , 2000, Journal of hepatology.
[20] S. Kawasaki,et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. , 2003, Journal of hepatology.
[21] A. Burroughs,et al. A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability , 2012, Annals of Surgical Oncology.
[22] A J Davis,et al. Repopulation of tumour cells between cycles of chemotherapy: a neglected factor. , 2000, The Lancet. Oncology.
[23] Y. Shibayama,et al. Clinicopathological Risk Factors for Recurrence within One Year after Initial Hepatectomy for Hepatocellular Carcinoma , 2011, The American surgeon.
[24] C. Sakakura,et al. Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy. , 2015, World journal of gastroenterology.
[25] W. Lau,et al. Partial Hepatectomy With Wide Versus Narrow Resection Margin for Solitary Hepatocellular Carcinoma: A Prospective Randomized Trial , 2007, Annals of surgery.
[26] I. Ng,et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. , 2007, Gastroenterology.
[27] X. Guan,et al. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway , 2008, Oncogene.
[28] S. Fan,et al. Significance of CD90+ cancer stem cells in human liver cancer. , 2008, Cancer cell.
[29] S. Gallinger,et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. , 2006, Journal of the American College of Surgeons.
[30] K. Boudjema,et al. Adjuvant intra‐arterial injection of iodine‐131–labeled lipiodol after resection of hepatocellular carcinoma , 2003, Hepatology.
[31] Yasuo Ohashi,et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial , 2000, The Lancet.